# Pilot Study of a Raltegravir Based NRTI Sparing Regimen

> **NCT00814879** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 60 (actual)

## Conditions studied

- Acquired Immune Deficiency Syndrome
- AIDS
- Human Immunodeficiency Virus
- HIV Infections

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Atazanavir
- **OTHER:** Standard treatment regimen

## Key facts

- **NCT ID:** NCT00814879
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-02-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814879, "Pilot Study of a Raltegravir Based NRTI Sparing Regimen". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00814879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*